These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 710507)

  • 1. Stimulation of prolactin release by vasoactive intestinal peptide (VIP).
    Ruberg M; Rotsztejn WH; Arancibia S; Besson J; Enjalbert A
    Eur J Pharmacol; 1978 Oct; 51(3):319-20. PubMed ID: 710507
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro stimulation of prolactin release by vasoactive intestinal peptide.
    Samson WK; Said SI; Snyder G; McCann SM
    Peptides; 1980; 1(4):325-32. PubMed ID: 7301635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vasoactive intestinal polypeptide on prolactin release in vitro.
    Shaar CJ; Clemens JA; Dininger NB
    Life Sci; 1979 Dec 10-17; 25(24-25):2071-4. PubMed ID: 537469
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal peptide (VIP)].
    Rotsztejn W; Benoist L; Besson J; Duval J
    C R Seances Acad Sci D; 1980 Mar; 290(12):791-3. PubMed ID: 6769606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of vip-induced prolactin release.
    Rotsztejn WH; Benoist L; Besson J; Beraud G; Bluet-Pajot MT; Kordon C; Rosselin G; Duval J
    Neuroendocrinology; 1980 Oct; 31(4):282-6. PubMed ID: 7422069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin release by vasoactive intestinal polypeptide in rats.
    Kato Y; Iwasaki Y; Iwasaki J; Abe H; Yanaihara N; Imura H
    Endocrinology; 1978 Aug; 103(2):554-8. PubMed ID: 744101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin-releasing activity of porcine intestinal peptide (PHI-27).
    Samson WK; Lumpkin MD; McDonald JK; McCann SM
    Peptides; 1983; 4(6):817-9. PubMed ID: 6689504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VIP stimulates prolactin release in women.
    Ottesen B; Andersen AN; Gerstenberg T; Ulrichesen H; Manthorpe T; Fahrenkrug J
    Lancet; 1981 Sep; 2(8248):696. PubMed ID: 6116075
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulatory effect of peptide histidine isoleucine amide 1-27 on prolactin release in the rat.
    Kaji H; Chihara K; Abe H; Minamitani N; Kodama H; Kita T; Fujita T; Tatemoto K
    Life Sci; 1984 Aug; 35(6):641-7. PubMed ID: 6431217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motilin stimulates growth hormone release in vitro.
    Samson WK; Lumpkin MD; McCann SM
    Brain Res Bull; 1982 Feb; 8(2):117-21. PubMed ID: 6121613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release.
    Gourdji D; Bataille D; Vauclin N; Grouselle D; Rosselin G; Tixier-Vidal A
    FEBS Lett; 1979 Aug; 104(1):165-8. PubMed ID: 89971
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of nitric oxide in control of prolactin release by the adenohypophysis.
    Duvilanski BH; Zambruno C; Seilicovich A; Pisera D; Lasaga M; Diaz MC; Belova N; Rettori V; McCann SM
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):170-4. PubMed ID: 7529411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vasoactive intestinal peptide (VIP) on somatostatin inhibition of pituitary growth hormone secretion in vitro.
    Tapia-Arancibia L; Arancibia S; Bluet-Pajot MT; Enjalbert A; Epelbaum J; Priam M; Kordon C
    Eur J Pharmacol; 1980 May; 63(2-3):235-6. PubMed ID: 6103817
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasoactive intestinal peptide, but not pituitary adenylate cyclase-activating peptide, modulates the responsiveness of the gonadotroph to LHRH in man.
    Hammond PJ; Talbot K; Chapman R; Ghatei MA; Bloom SR
    J Endocrinol; 1993 Jun; 137(3):529-32. PubMed ID: 8371083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
    Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of prolactin secretion in rhesus monkeys by vasoactive intestinal polypeptide.
    Frawley LS; Neill JD
    Neuroendocrinology; 1981 Aug; 33(2):79-83. PubMed ID: 7266772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effect of vasoactive intestinal polypeptide and peptide histidine isoleucine on prolactin secretion by the bullfrog pituitary gland.
    Koiwai K; Kikuyama S; Seki T; Yanaihara N
    Gen Comp Endocrinol; 1986 Nov; 64(2):254-9. PubMed ID: 3493951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced vasoactive intestinal peptide-induced prolactin secretion from anterior pituitary cells of incubating turkeys (Meleagris gallopavo).
    el Halawani ME; Silsby JL; Mauro LJ
    Gen Comp Endocrinol; 1990 Oct; 80(1):138-45. PubMed ID: 2272474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of in vitro prolactin release by vasoactive intestinal peptide.
    Enjalbert A; Arancibia S; Ruberg M; Priam M; Bluet-Pajot MT; Rotsztejn WH; Kordon C
    Neuroendocrinology; 1980 Sep; 31(3):200-4. PubMed ID: 7413020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal polypeptide stimulation of cyclic AMP formation in rat central nervous system.
    Kaneko T; Nakaya S; Saito S; Yanaihara N; Oka H
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():7-10. PubMed ID: 6112141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.